Cognitive Behavioural Therapy/Metacognitive Therapy for Low Self Esteem

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Oslo

About this trial

The goal for this clinical trial is to explore the effect of CBT/MCT on the treatment of low self esteem. 20 patients with low self-esteem will be selected and distributed into two either MCT or a CBT

We aim in this study to (1) evaluate the accessibility and effectiveness of MCT and CBT in treating low self-esteem, (2) investigate the patterns of change and the mechanisms of action involved during treatment, and (3) examine the impact of meta-cognitions and neuropsychologial processes in the treatment response and any relapse prevention of low self-esteem.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Signed written informed consent obtained prior to entry in the study.

Scores below 15 on the Rosenberg Self-esteem Scale (RSE)

18 years or older.

Disqualifiers

Psychosis

Bipolar type 1

Current suicide intent

PTSD

Trial design

Design model

Parallel

Treatments tested in this trial

  • Cognitive behavioral therapy

    Behavioral

    The CBT is based on the treatment manual written by Fennell (1997). The patients receiving CBT will be treated for 8 sessions, with weekly session of 45-60 minutes duration.

  • Metacognitive therapy

    Behavioral

    The meta-cognitive treatment program is based on Wells's metacognitive therapy (Wells, 2013). The patients receiving meta-cognitive therapy will be treated for 8 sessions, with weekly session of 45-60 minutes duration.

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Cognitive behavioral therapyExperimental treatment 1 intervention
Group B: Metacognitive therapyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Rosenberg Self Esteem Scale

The purpose of the 10 item RSE scale is to measure self-esteem.The scale ranges from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem

Time frame
Baseline scores each week over two weeks before pre-treatment, pre-treatment, each session each week over 8 weeks , post-treatment (8 weeks), and six months follow up

Secondary outcomes

1

GAD-7

The Generalised Anxiety Disorder Assessment (GAD-7) is a seven-item instrument that is used to measure or assess the severity of generalised anxiety disorder (GAD). Each item asks the individual to rate the severity of his or her symptoms over the past two weeks. Response options include "not at all", "several days", "more than half the days" and "nearly every day". Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively.

Time frame
Baseline scores each week over two weeks before pre-treatment, pre-treatment, each session each week over 8 weeks, post-treatment (8 weeks) and six months follow up
2

PHQ-9

The PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression. Total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively

Time frame
Baseline scores each week over two weeks before pre-treatment, pre-treatment, each session each week over 8 weeks , post-treatment (8 weeks) and six months follow up

Other outcomes

1

Penn State Worry Questionnaire

The PSWQ is a 16-item self-report scale designed to measure the trait of worry in adults. Worry is regarded as a dominant feature of generalised anxiety disorder (GAD). The scale measures the excessiveness, generality, and uncontrollable dimensions of worry.cores range from 16 to 80 with higher scores indicative of higher levels of trait worry. Scores can be in the following severity ranges. 29 or less: Not anxious or a worrier 30-52: Bothered by worries but below clinical range for worry 52-65: Currently have some problems with worry and may benefit from treatment 66 or more: Chronic worrier and in need of treatment to target this problem

Time frame
Pre-, post-treatment (8 weeks) and six months follow up
2

Inventory of Interpersonal Problems (IIP-64)

The Inventory of Interpersonal Problems (IIP) is a self-report instrument that identifies a person's most salient interpersonal difficulties.The questionnaire is divided into two parts. The first part consists of statements about behavior inhibitions commenced 'It's hard for me to…' and the second part includes items that focus on behavioral excesses, 'Things that I do too much…'. The participant responds to the items on a 5-point Likert scale, ranging from 0 = 'Not at all' to 4 = 'Extremely'. Higher scores indicate more interpersonal distress. The items are grouped into eight subscales (with eight items each) corresponding to the octants in the interpersonal circumplex: domineering/controlling (PA), vindictive/self-centered (BC), cold/distant (DE), socially inhibited (FG), non-assertive (HI), overly accommodating (JK), self-sacrificing (LM) and intrusive/needy (NO).

Time frame
Pre-, post-treatment (8 weeks) and six months follow up after treatment
3

Ruminative Response Scale

The RRS was developed to more directly and reliably assess rumination that is related to, but not confounded by depression. The 22 items of the RRS measure two aspects of rumination, brooding and reflective pondering.The total score ranges from 22-88, with higher scores indicating increased tendency to ruminate.

Time frame
Pre-, post-treatment (8 weeks) and six months follow up after treatment
4

Robson Self Concept Questionnaire

The SCQ is a self-report scale measuring self-esteem. It consists of 30 items (e.g., "I have control over my life," "I feel emotionally mature," "I can like myself even if others don't".It consists of 30 statements to which respondents indicate their level of agreement on a 7-point scale. The typical mean score in control samples being around 140 with a standard deviation of 20.

Time frame
Pre-, post-treatment (8 weeks) and six months follow up after treatment

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Oslo

Lead sponsor

Norwegian University of Science and Technology

Collaborator

This trial is not recruiting at the moment. You can still explore other options: